Abiopharma

Gevo Announces First Quarter 2026 Results and Provides Update on Expansion and Alcohol-to-Jet Project

Quest Resource Holding Corporation Reports First Quarter 2026 Financial Results

AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for May 2026

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

VTEX Reports First Quarter 2026 Financial Results

Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update

Celldex Reports First Quarter Financial Results and Provides Corporate Update

(99% Neutral) GIGCAPITAL7 CORP. (GIGGW) Files Form 8-K

(99% Neutral) GEN DIGITAL INC. (GEN) Reports Q2 2026 Financial Results

TAHL CINDY 🟡 adjusted position in 0 shares (2 derivative) of FATE THERAPEUTICS INC (FATE) at $1.32 Transaction Date: May 06, 2026 | Filing ID: 211820

(99% Neutral) MOUNTAIN CREST ACQUISITION 6 CORP. (MCAHU) Reports Q2 2026 Financial Results

(35% Negative) BLEND LABS, INC. (BLND) Reports Q2 2026 Financial Results

(99% Neutral) SMART POWERR CORP. (CREG) Files Form 8-K

(30% Negative) QUEST RESOURCE HOLDING CORP (QRHC) Reports Q2 2026 Financial Results